Gut Microbiota: Key Player, Therapeutic Target
Received Date: Jun 02, 2025 / Published Date: Jun 30, 2025
Abstract
The gut microbiota is a pivotal factor in the development of obesity and metabolic syndrome. Dysbiosis contributes to inflammation and altered energy metabolism. Key mechanisms involve Short-Chain Fatty Acids (SCFAs) and diet-induced shifts in microbial composition affecting host energy, insulin sensitivity, and inflammatory responses. Therapeutic strategies include prebiotics, probiotics, Fecal Microbiota Transplantation (FMT), and dietary interventions. The gut microbiota-brain axis also influences appetite and energy balance. Early-life microbial programming impacts long-term obesity risk. Collectively, these studies highlight the gut microbiota as a critical target for understanding and managing obesity.
Citation: Petrova DA (2025) Gut Microbiota: Key Player, Therapeutic Target. jowt 15: 814.
Copyright: 漏 2025 Dr. Anna Petrova This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 550
- [From(publication date): 0-0 - Apr 07, 2026]
- Breakdown by view type
- HTML page views: 414
- PDF downloads: 136
